{
  "docId": "019de071-b48b-74ad-8fcb-69ba4c0494fb",
  "docSlug": "4047dd7a7e0f28ca31128b58ef648c55",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 39,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "roadmap",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a split layout to contrast 'What's next' (early pipeline) with 'What's now' (Phase III/lifecycle).",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-b48b-74ad-8fcb-69ba4c0494fb/20",
  "deckHref": "/decks/019de071-b48b-74ad-8fcb-69ba4c0494fb",
  "deckJsonHref": "/decks/019de071-b48b-74ad-8fcb-69ba4c0494fb.json",
  "deckAnchorHref": "/decks/019de071-b48b-74ad-8fcb-69ba4c0494fb#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.02,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "WEE1 = tyrosine kinase WEE1; CD73 = ecto-5'-nucleotidase; CDK9 = cyclin-dependent kinase 9 MCL1 = induced myeloid leukaemia cell differentiation protein; PD-1 = programmed cell death protein 1; TIGIT = T-cell immunoreceptor with immunoglobulin and ITIM domains; ATR = ataxia telangiectasia and rad3-related kinase; CTLA-4 = cytotoxic T-lymphocyte-associated protein 4; Bcl-2 = B-cell lymphoma 2; TIM3 = T-cell immunoglobulin domain and mucin domain 3.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46749d7f-0d1d-44c2-bdea-8d191516a6cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.52,
        "w": 0.47,
        "x": 0.03,
        "y": 0.408
      },
      "kind": "table",
      "text": "Selected Phase I/II new medicines",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e79d147-eb40-412b-954d-c3a233bd922f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.32,
        "x": 0.658,
        "y": 0.21
      },
      "kind": "table",
      "text": "Phase III new medicines and lifecycle management",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa0f7f81-7a9d-40a8-bcdc-59fdd49d58a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Solid pipeline moving forward",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec307afd-3ed9-4a8a-a93a-61a1d527c82d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.38,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "What's next in Oncology",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d5704e9-f77e-483f-9967-f41748a44e34",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 14,
      "beatId": "c438a04c-1fcd-49aa-a3b3-c1d3c21b10b6",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document showcases the company's strong presence in Oncology, with key highlights and positive data.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 14,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "f40460eb-a408-4c4b-b4fa-e51e50631502",
      "evidence": "The document uses the golden circle to present the company's Oncology pipeline and highlight its potential for growth.",
      "position": 1,
      "objective": "To showcase the company's strong presence in Oncology and demonstrate its potential for growth.",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}